Publications

2023

Sandini M., Paiella S., Cereda M., Angrisani M., Capretti G., Famularo S., Giani A., Roccamatisi L., Fontani A., Malleo G., Salvia R., Roviello F., Zerbi A., Bassi C., Gianotti L.

Frontiers in nutrition

Bioelectrical impedance analysis (BIA) can be a useful tool for predicting postoperative outcomes in patients with pancreatic cancer. In fact, the FM/FFM ratio turns out to be a marker of survival.

2023

Schmidt M., Chong M., Klassen O., Wiskemann J., Steindorf K.

International journal of cancer

This study on cancer patients shows that phase angle (PhA) correlates with physical and emotional fatigue, with influences from BMI, exercise, endurance exercise, and chemotherapy. This parameter may help classify different types of fatigue that require specific treatments.

2023

García-García C., Vegas-Aguilar I. M., Rioja-Vázquez R., Cornejo-Pareja I., Tinahones F., García-Almeida J.

Nutrients

Low phase angle (≤5.6° in cancer patients, ≤5.9° in men, ≤5.3° in women) and rectus femoris cross-sectional area (RFCSA) (≤4.47 cm²/m² in cancer patients, ≤4.47° in men, ≤2.73° in women) are markers of mortality risk in cancer patients.

2020

Mueller T., Reik L., Prokopchuk O., Friess H., Martignoni M.

Medicine

This study on cancer patients compares body composition obtained by computed tomography (CT) and by bioelectrical impedance analysis (BIA). A significant correlation between the two methods is shown. These results suggest that BIA may be a valuable diagnostic tool for assessing muscle and fat mass, even in malnourished patients.

2021

Cereda E., Pedrazzoli P., Lobascio F., Masi S., Crotti S., Klersy C., Turri A., Stobäus N., Tank M., Franz K., Cutti S., Giaquinto E., Filippi A., Norman K., Caccialanza R.

Clinical nutrition

Data from 1217 Italian and German cancer patients show that low FFMI values are associated with reduced survival and impaired quality of life. These findings underscore the importance of considering body composition in cancer patients.

2020

Caccialanza R., Cereda E., Klersy C., Brugnatelli S., Borioli V., Ferrari A., Caraccia M., Lobascio F., Pagani A., Delfanti S., Aprile G., Reni M., Rimassa L., Melisi D., Cascinu S., Battistini L., Candiloro L e Pedrazzoli P.

Therapeutic Advances in Medical Oncology

This is a randomized, multicenter study, aimed to evaluate in patients with metastatic gastric cancer at risk of malnutrition, undergoing first-line chemotherapy , the efficacy, in terms of clinical outcomes and QoL (Quality of Life), of early systematic administration of supplemental parenteral nutrition in addition to the nutritional counseling compared to the nutritional counseling alone.
View the Clinical trial : www.clinicaltrials.gov

2019

Caccialanza Riccardo, et al.

Supportive Care in Cancer

The bicentric study conducted on hypophagic cancer patients at nutritional risk, with contraindications for enteral nutrition, evaluates the effects of supplemental parenteral nutrition (SPN) through BIVA analysis, handgrip strength and serum prealbumin.

2020

Cereda E., Caraccia M., Klersy C., Cappello S., Turri A., Borioli V., Palladini G

Clinical Nutrition

Validation study of the NUTRIGRAM® scale as a new prognostic body composition parameter to identify cancer patients at nutritional risk who require early nutritional support.